Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Essential Hypertension × Adrenergic beta-Antagonists × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Hemangioma 3 Breast Neoplasms 3 Heart Failure 2 Smoldering Multiple Myeloma 1 Postoperative Nausea and Vomiting 1 Pain, Postoperative 1 Pain 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Hyperalgesia 1 Hemangioma, Capillary 1 Essential Hypertension 1

Interventions

candesartan 1 aliskiren 1 Exercise 1 Enalapril 1 Diuretics 1 Calcium Channel Blockers 1 Adrenergic beta-Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05972785 2024-08-21

Long-term Use of CCB and Breast Cancer Risk

Curtin University

Active not recruiting

68,500 enrolled

Essential Hypertension, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡